THYMUS mediated immune surveillance has been indicated as an important mechanism in protecting the host from cancers arising from the reticuloendothelial system (Burnet, 1970; Good and Finstad, 1969; Hollinshead, Glew and Bunnag, 1970; Eilber and Morton, 1970) . The effectiveness of thymic hormones in stimulating immune recognition and elimination of cancers arising in the reticuloendothelial system is unknown.
In 1966 Goldstein, Slater and White described a dialyzable glycoprotein extract obtained from calf thymus which they labelled thymosin. In vivo studies indicated that this thymic extract (Fraction 3) enhanced allograft rejection, restored immunological competence of neonatally thymectomized mice, reduced the incidence of wasting disease and was partially effective in developing resistance to virus induced murine sarcoma tumours (Hardy et al., 1968; Law, Goldstein and White, 1968; Asanuma, Goldstein and White, 1970; Zisblatt et al., 1970) .
In vitro studies by Bach et al. (1971) have indicated that thymosin induces differentiation of primitive cells of bone marrow origin (B cells) into long lived lymphocytes bearing theta antigen (T cells). Incubation of B cells with thymosin has been shown to produce a new population of lymphoid cells with sensitivity to azathioprine, antilymphocyte or antitheta sera. Miller, Schmiege and Rule (1973) Table I . TE primed lymphoid cells were obtained by injecting 1 ml of 15 mg/ml buffered TE/rat intravenously into a group of 9 rats. Each rat received one injection every 48 hours for a total of 3 injections. Twenty-four hours after the last injection the rats were sacrificed. The thymus, spleen and mesenteric lymph nodes from TE treated rats were removed. Untreated rats were also sacrificed and thymus, spleen and mesenteric lymph nodes were similarly obtained. These were washed in saline, cut into small pieces, homogenized gently by hand and the homogenate sieved through cheese cloth before spinning at 2000 rev/min for 10 min in an international clinical centrifuge. The packed cells obtained were made up to a total volume of 5 ml in tris buffer. The concentration of white blood cells was determined as described by Todd et al. (1957) (1968) to enhance cell mediated immunity and allograft rejection. Evidence for increased resistance to Moloney virus induced sarcoma with thymosin treatment was also reported by Zisblatt et al. (1970) . The present investigation suggests that intravenously injected thymic extract (TE) was able to bring about certain percentages of tumour rejections in rats carrying a lethal leukaemia. The results suggested that optimal effectiveness of TE therapy in rendering complete remission from cancer depended upon the time treatment was started. Leukaemic rats receiving 5 mg TE per rat per day from Day +1 to Day + 4 showed the best TE induced tumour remission rate. Further experimentation would be needed to establish these data firmly, however.
Rats that received rabbit anti-rat thymocyte serum (ATS), an immunosuppressive agent (Taub, 1970) (Miller et al., 1973) .
Thymus mediated immune surveillance in cancers of the reticuloendothelial system have been shown to be of great importance (Burnet, 1970; Good and Finstad, 1969 
